Kouzo Yamada

2.3k citations
112 papers · 1.7k indexed · h-index 21
Topics
Lung Cancer Treatments and Mutations (57 papers)Lung Cancer Diagnosis and Treatment (56 papers)Lung Cancer Research Studies (34 papers)

In The Last Decade

Kouzo Yamada

105 papers receiving 1.7k citations

Peers

Kouzo Yamada
Comparison fields: 5 of 80
  • Pulmonary and Respiratory Medicine 1.2k
  • Oncology 588
  • Radiology, Nuclear Medicine and Imaging 380
  • Molecular Biology 321
  • Physiology 154
Replace Shun-ichi Watanabe with:
Shun-ichi Watanabe Japan
Chiaki Endo Japan
Yasuhiro Tsutani Japan
Masakazu Sugaya Japan
Yoichi Kameda Japan
Wulf Sienel Germany
Sukki Cho South Korea
Yoshihiko Koshiishi Japan
Taishi Harada Japan
Kouzo Yamada relative to Shun-ichi Watanabe Japan Shun-ichi Watanabe's profile →
Citations per field
00.5×1.5×2.2×
Shun-ichi Watanabe · 1×
Citations per year

Countries citing papers authored by Kouzo Yamada

Since Specialization
Citations

This map shows the geographic impact of Kouzo Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kouzo Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kouzo Yamada more than expected).

Fields of papers citing papers by Kouzo Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kouzo Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kouzo Yamada. The network helps show where Kouzo Yamada may publish in the future.

Co-authorship network of co-authors of Kouzo Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Kouzo Yamada. A scholar is included among the top collaborators of Kouzo Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kouzo Yamada. Kouzo Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 9
3 25
4 30
5 13
6 12
7 19
8 5
9 22
10 3
11 1
12 2
13 18
14 1
15 1
16 0
17 2
18 2
19 0
20 2

About Kouzo Yamada

Kouzo Yamada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 112 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (57 papers), Lung Cancer Diagnosis and Treatment (56 papers) and Lung Cancer Research Studies (34 papers). The work is most often cited by research in Microbiology (33 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Oncology (588 citations). Kouzo Yamada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Haruhiko Nakayama, Fumihiro Oshita, Haruhiro Saito, Kazumasa Noda, Hiroyuki Ito, Tomoyuki Yokose, Tetsuro Kondo, Yoichi Kameda, Shuji Murakami and Mizuki Ikehara. Their work appears in journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026